title: Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation.
authors.affiliation: Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, Northwest Lipid Laboratory, University of Washington, Seattle, Washington, USA.
authors.forename: John D
authors.initials: JD
authors.lastname: Brunzell
authors.forename: Michael
authors.initials: M
authors.lastname: Davidson
authors.forename: Curt D
authors.initials: CD
authors.lastname: Furberg
authors.forename: Ronald B
authors.initials: RB
authors.lastname: Goldberg
authors.forename: Barbara V
authors.initials: BV
authors.lastname: Howard
authors.forename: James H
authors.initials: JH
authors.lastname: Stein
authors.forename: Joseph L
authors.initials: JL
authors.lastname: Witztum
mesh_terms: D053299:Apolipoprotein B-100 / Q000097:blood; D001161:Arteriosclerosis / Q000097:blood / Q000503:physiopathology; D002318:Cardiovascular Diseases / Q000097:blood / Q000503:physiopathology* / Q000517:prevention & control; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008074:Lipoproteins / Q000097:blood*; D018570:Risk Assessment; D012307:Risk Factors; D012955:Societies, Medical; D014280:Triglycerides / Q000097:blood; D014481:United States
chemical_list: D053299:Apolipoprotein B-100; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008074:Lipoproteins; D014280:Triglycerides